Chi Advisors LLC Blueprint Medicines Corp Transaction History

Chi Advisors LLC

$203 Million
Q3 2023

A detailed history of Chi Advisors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Chi Advisors LLC holds 92,888 shares of BPMC stock, worth $8.29 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

92,888

Holding current value

$8.29 Million

% of portfolio

2.3%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $4.36 Million - $6.13 Million	92,888 New	92,888 $4.66 Million
Q2 2021 Aug 11, 2021	SELL	$82.78 - $101.0 $289,730 - $353,500	-3,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $181,420 - $216,560	-2,000 Reduced 36.36%	3,500 $340,000
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $92,080 - $124,480	-1,000 Reduced 15.38%	5,500 $617,000
Q3 2020 Nov 12, 2020	SELL	$66.45 - $92.7 $365,475 - $509,850	-5,500 Reduced 45.83%	6,500 $603,000
Q2 2020 Aug 12, 2020	SELL	$57.09 - $79.27 $1.37 Million - $1.9 Million	-24,000 Reduced 66.67%	12,000 $936,000
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $481,100 - $822,200	10,000 Added 38.46%	36,000 $2.11 Million
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $533,840 - $660,720	8,000 Added 44.44%	26,000 $2.08 Million
Q3 2019 Nov 12, 2019	BUY	$72.9 - $101.41 $1.31 Million - $1.83 Million	18,000 New	18,000 $1.32 Million

Others Institutions Holding BPMC

# of Institutions

337

Shares Held

62M

Call Options Held

987K

Put Options Held

578K

Black Rock Inc. New York, NY

6.65M
Shares

$593 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

6.54M
Shares

$584 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.87M
Shares

$524 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

3.24M
Shares

$289 Million
0.06% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.46M
Shares

$220 Million
8.22% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.33B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Account